445
Views
39
CrossRef citations to date
0
Altmetric
Original Article

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet’s Disease

, , , , , , , , , , , , & ORCID Icon show all
Pages 298-304 | Received 11 Aug 2017, Accepted 09 Aug 2018, Published online: 27 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Antonio Vitale, Valeria Caggiano, Virginia Berlengiero, Maria Orsetta Perfetti, Jurgen Sota, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2023) Comparing biologic options for the management of Behcet’s disease-related uveitis. Expert Review of Clinical Immunology 19:3, pages 315-328.
Read now
Daniel Pak & Hyon Ju Park. (2023) Behcet disease: an undifferentiating and complex vasculitis. Postgraduate Medicine 135:sup1, pages 33-43.
Read now
Jeanne Gunzinger, Phoebe Moore, Athimalaipet Ramanan & Andrew Dick. (2021) Adalimumab in the treatment of pediatric patients with chronic noninfectious anterior uveitis. Expert Review of Ophthalmology 16:4, pages 231-241.
Read now
Giuseppe Lopalco, Donato Rigante, Antonio Lopalco, Giacomo Emmi, Vincenzo Venerito, Antonio Vitale, Giovanna Capozio, Nunzio Denora, Luca Cantarini & Florenzo Iannone. (2020) Safety of systemic treatments for Behçet’s syndrome. Expert Opinion on Drug Safety 19:10, pages 1269-1301.
Read now
Ilknur Tugal-Tutkun & Pinar Çakar Özdal. (2020) Behçet’s disease uveitis: is there a need for new emerging drugs?. Expert Opinion on Emerging Drugs 25:4, pages 531-547.
Read now
Carla Gaggiano, Jurgen Sota, Stefano Gentileschi, Valeria Caggiano, Salvatore Grosso, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2020) The current status of biological treatment for uveitis. Expert Review of Clinical Immunology 16:8, pages 787-811.
Read now

Articles from other publishers (33)

Lisia Barros Ferreira, Liam M. Ashander, Yuefang Ma, Binoy Appukuttan, Keryn A. Williams, Giles Best & Justine R. Smith. (2024) Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells. Cytokine 173, pages 156407.
Crossref
Patricia Fanlo Mateo. (2023) Uveítis. Medicina Clínica 160:6, pages 258-260.
Crossref
Patricia Fanlo Mateo. (2023) Uveitis. Medicina Clínica (English Edition) 160:6, pages 258-260.
Crossref
Teresa Giani, Angela Flavia Luppino & Giovanna Ferrara. (2023) Treatment Options in Pediatric Behçet’s Disease. Pediatric Drugs 25:2, pages 165-191.
Crossref
Masaru Takeuchi, Yoshihiko Usui, Kenichi Namba, Hiroshi Keino, Masaki Takeuchi, Hiroshi Takase, Koju Kamoi, Keitaro Hase, Takako Ito, Kei Nakai, Kazuichi Maruyama, Eri Kobayashi, Hisashi Mashimo, Tomohito Sato, Nobuyuki Ohguro, Junko Hori, Annabelle A. Okada, Koh-hei Sonoda, Nobuhisa Mizuki & Hiroshi Goto. (2023) Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study. Frontiers in Medicine 10.
Crossref
Meini Chen, Rong Rong & Xiaobo Xia. (2022) Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. Journal of Neuroinflammation 19:1.
Crossref
Xue Wu, Mengying Tao, Ling Zhu, Ting Zhang & Ming Zhang. (2022) Pathogenesis and current therapies for non-infectious uveitis. Clinical and Experimental Medicine 23:4, pages 1089-1106.
Crossref
Emanuela Del Giudice, Jurgen Sota, Francesca Orlando, Ludovica Picciano, Rolando Cimaz, Luca Cantarini & Angela Mauro. (2022) Off-label use of canakinumab in pediatric rheumatology and rare diseases. Frontiers in Medicine 9.
Crossref
Shereen H. Aboul Naga, Lameece Moustafa Hassan, Radwa T. El Zanaty, Mohammad Refaat, Rana H. Amin, Gaafar Ragab & Mahmoud M. Soliman. (2022) Behçet uveitis: Current practice and future perspectives. Frontiers in Medicine 9.
Crossref
Lori Broderick & Hal M. Hoffman. (2022) IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. Nature Reviews Rheumatology 18:8, pages 448-463.
Crossref
E. L. Nasonov & M. Yu. Samsonov. (2022) The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist). Rheumatology Science and Practice 60:3, pages 280-298.
Crossref
Simple GuptaK. ShyamsundarMohini Agrawal, Nitin VichareJyotirmay Biswas. (2022) Current Knowledge of Biologics in Treatment of Noninfectious Uveitis. Journal of Ocular Pharmacology and Therapeutics 38:3, pages 203-222.
Crossref
T.B. van der Houwen, P.M. van Hagen & J.A.M. van Laar. (2022) Immunopathogenesis of Behçet's disease and treatment modalities. Seminars in Arthritis and Rheumatism 52, pages 151956.
Crossref
Petros Efthimiou, Olga Petryna, Priscila Nakasato & Apostolos Kontzias. (2022) New insights on multigenic autoinflammatory diseases. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211178.
Crossref
Jingjing Chen & Xu Yao. (2021) A Contemporary Review of Behcet’s Syndrome. Clinical Reviews in Allergy & Immunology 61:3, pages 363-376.
Crossref
Janice Tiao, Grace Shin, Sara Al Janahi, Kee Yang Chung, Do Young Kim, Je-Ho Mun, Jason B. Lee & Hye Jin Chung. (2021) Skin diseases in Asian individuals that you do not want to miss: A selection of unique or relatively more common conditions in Asian populations. Clinics in Dermatology 39:5, pages 879-886.
Crossref
Jurgen Sota, Stefano Gentileschi, Antonio Vitale, Carla Gaggiano, Giuseppe De Bartolo, Maria Teresa BiancoBruno Frediani, Gian Marco Tosi, Luca Cantarini & Claudia Fabiani. (2021) Effectiveness of SB5, an Adalimumab Biosimilar, in Patients With Noninfectious Uveitis: A Real-Life Monocentric Experience. Asia-Pacific Journal of Ophthalmology 10:4, pages 360-365.
Crossref
Qiuyun Xu, Jie Zhang, Tingyu Qin, Jingyin Bao, Hongtao Dong, Xiaorong Zhou, Shengping Hou & Liming Mao. (2021) The role of the inflammasomes in the pathogenesis of uveitis. Experimental Eye Research 208, pages 108618.
Crossref
Fatma Alibaz-Oner & Haner Direskeneli. (2021) Advances in the Treatment of Behcet’s Disease. Current Rheumatology Reports 23:6.
Crossref
Erkan Alpsoy, Pietro Leccese, Giacomo Emmi & Shigeaki Ohno. (2021) Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach. Frontiers in Medicine 8.
Crossref
Ummusen Kaya Akca & Ezgi Deniz Batu. (2021) SIMILARITIES AND DIFFERENCES BETWEEN FAMILIAL MEDITERRANEAN FEVER AND BEHÇET’S DISEASE. Central Asian Journal of Medical Hypotheses and Ethics 2:1, pages 43-50.
Crossref
Kailei Guo & Xiaomin Zhang. (2021) Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis. Journal of Immunology Research 2021, pages 1-19.
Crossref
Hana Malcova, Tomas Milota, Zuzana Strizova, Dita Cebecauerova, Ilja Striz, Anna Sediva & Rudolf Horvath. (2021) Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?. Frontiers in Pharmacology 11.
Crossref
Silvia Stefania, Ripalta Colia, Rotondo Cinzia, Addolorata Corrado & Francesco Paolo Cantatore. (2021) Off-label use of anti-IL-1 drugs in rheumatic diseases. International Journal of Immunopathology and Pharmacology 35, pages 205873842110065.
Crossref
Lisia Barros Ferreira, Anthony J. SmithJustine R. Smith. (2021) Biologic Drugs for the Treatment of Noninfectious Uveitis. Asia-Pacific Journal of Ophthalmology 10:1, pages 63-73.
Crossref
Murat Kürtüncü, Burcu Altunrende & Gülşen Akman. 2021. Neuro-Behçet’s Disease. Neuro-Behçet’s Disease 123 149 .
Kader Cetin Gedik, Micol Romano, Roberta A. Berard & Erkan Demirkaya. (2020) An Overview of Conventional and Recent Treatment Options for Behcet’s Disease. Current Treatment Options in Rheumatology 6:2, pages 99-127.
Crossref
Jurgen Sota, Luca Cantarini, Antonio Vitale, Arianna Sgheri, Stefano Gentileschi, Valeria Caggiano, Viviana Gelardi, Bruno Frediani, Gian Marco Tosi & Claudia Fabiani. (2020) Long-Term Outcomes of Behçet’s Syndrome-Related Uveitis: A Monocentric Italian Experience. Mediators of Inflammation 2020, pages 1-8.
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis 326 349 .
Vedat Hamuryudan, Ina Kötter & Hasan Tüzün. 2020. Behçet Syndrome. Behçet Syndrome 279 305 .
Giacomo Emmi & Domenico Prisco. (2019) Behçet’s syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments. Internal and Emergency Medicine 14:5, pages 639-643.
Crossref
Emire Seyahi. (2019) Phenotypes in Behçet’s syndrome. Internal and Emergency Medicine 14:5, pages 677-689.
Crossref
Alessandra Bettiol, Elena Silvestri, Gerardo Di Scala, Amedeo Amedei, Matteo Becatti, Claudia Fiorillo, Giuseppe Lopalco, Carlo Salvarani, Luca Cantarini, Alessandra Soriano & Giacomo Emmi. (2019) The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review. Rheumatology International 39:6, pages 971-990.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.